Literature DB >> 8086679

Role of bacterial translocation in necrotizing enterocolitis.

E A Deitch1.   

Abstract

The intestinal mucosa functions as a major local defense barrier preventing bacteria that colonize the gut from invading organs and tissues. Under certain circumstances, bacteria colonizing the gastrointestinal tract can cross the gut mucosal barrier to infect the mesenteric lymph node and systemic organs via a process termed bacterial translocation. Factors that promote the translocation of bacteria or endotoxin from the gut include bacterial overgrowth with gram-negative enteric bacilli, impaired host immune defenses and injury to the gut mucosa resulting in increased intestinal permeability. These same promoting factors are present in patients at increased risk of developing necrotizing enterocolitis. Consequently, this review focuses on the potential role of bacterial and endotoxin translocation from the gut in the pathogenesis of necrotizing enterocolitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8086679     DOI: 10.1111/j.1651-2227.1994.tb13239.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  19 in total

1.  T-cell-mediated mucosal immunity is attenuated in experimental necrotizing enterocolitis.

Authors:  A Anttila; H Kauppinen; A Koivusalo; P Heikkila; E Savilahti; R Rintala
Journal:  Pediatr Surg Int       Date:  2003-05-23       Impact factor: 1.827

2.  In vitro growth responses of bifidobacteria and enteropathogens to bovine and human lactoferrin.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Diane Dryja; Allen Leavens; Ronald L Neiswander; Haiping Qiao; Douglas DiRienzo; Pearay Ogra
Journal:  Dig Dis Sci       Date:  2003-07       Impact factor: 3.199

Review 3.  Necrotizing enterocolitis: a practical guide to its prevention and management.

Authors:  Pinaki Panigrahi
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  The role of polyunsaturated fatty acid supplementation in intestinal inflammation and neonatal necrotizing enterocolitis.

Authors:  M S Caplan; T Jilling
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

5.  Modeling the interactions of bacteria and Toll-like receptor-mediated inflammation in necrotizing enterocolitis.

Authors:  Julia Arciero; G Bard Ermentrout; Richard Siggers; Amin Afrazi; David Hackam; Yoram Vodovotz; Jonathan Rubin
Journal:  J Theor Biol       Date:  2012-12-10       Impact factor: 2.691

Review 6.  Neutropenic enterocolitis in adults: case series and review of the literature.

Authors:  Steven C Cunningham; Karim Fakhry; Barbara L Bass; Lena M Napolitano
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

7.  Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birthweight infants.

Authors:  Y K Siu; P C Ng; S C Fung; C H Lee; M Y Wong; T F Fok; K W So; K L Cheung; W Wong; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

Review 8.  Lactoferrin as a natural immune modulator.

Authors:  Jeffrey K Actor; Shen-An Hwang; Marian L Kruzel
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 9.  Probiotics for preterm infants?

Authors:  M Millar; M Wilks; K Costeloe
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-09       Impact factor: 5.747

10.  The study of the inhibition of the recombinant TACE prodomain to endotoxemia in mice.

Authors:  Xiaoou Li; Yuan Yan; Wei Huang; Yuzhen Yang
Journal:  Int J Mol Sci       Date:  2009-12-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.